Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Topic search: ALLERGY/IMMUNOLOGY/INFLAMMATION

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

 
Refine your search by entering keywords here:

Inflammation, Allergy, and Immunology Journal Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Diclofenac Sodium 1% Soft-patch Gel
Allen Loyd V Jr
Mar/Apr 2024
Pg. 134

Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals
Semighini Flavia
, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
Nov/Dec 2023
Pg. 454-460

Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base
Allen Loyd V Jr
Nov/Dec 2023
Pg. 492

Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike
, Kaiser Joe
Sep/Oct 2023
Pg. 368-380

Hydrocortisone 2% in Versapro Cream
Allen Loyd V Jr
Sep/Oct 2023
Pg. 416

Silver Sulfadiazine 1% and Hydrocortisone 2% Gel
Allen Loyd V Jr
Sep/Oct 2023
Pg. 422-423

The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan
, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Sep/Oct 2023
Pg. 431-439

Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Riepl Mike
, Kaiser Joe
Jul/Aug 2023
Pg. 284-293

Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
Jul/Aug 2023
Pg. 319

Cyclosporine Topical Gel Formulation
Allen Loyd V Jr
Jul/Aug 2023
Pg. 320-321

Dexamethasone 1 mg/mL in Oral Mix SF
Allen Loyd V Jr
Jul/Aug 2023
Pg. 322

Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt
Pramar Yahoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2023
Pg. 330-339

Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Riepl Mike
, Kaiser Joe
May/Jun 2023
Pg. 192-200

Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2023
Pg. 232-233

Methylene Blue 5-mg Capsules
Allen Loyd V Jr
May/Jun 2023
Pg. 236

Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Riepl Mike
Mar/Apr 2023
Pg. 98-107

Cyclosporine Topical Microemulsion
Allen Loyd V Jr
Mar/Apr 2023
Pg. 146

The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
Jan/Feb 2023
Pg. 22-23

Psoriasis Topical Ointment
Allen Loyd V Jr
Jan/Feb 2023
Pg. 57

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Curcumin 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2022
Pg. 509

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera
, Thompson Tara
Sep/Oct 2022
Pg. 378-384

Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
Sep/Oct 2022
Pg. 430

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 318

Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2022
Pg. 320

Indomethacin 1% Topical Gel
Allen Loyd V Jr
Jul/Aug 2022
Pg. 325-326

Psoriasis Topical Ointment
Allen Loyd V Jr
Jul/Aug 2022
Pg. 329

Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves
, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022
Pg. 336-341

Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle
Allen Loyd V Jr
May/Jun 2022
Pg. 236

Sirolimus 0.1% Ointment
Allen Loyd V Jr
May/Jun 2022
Pg. 240

Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 241

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
Mar/Apr 2022
Pg. 144

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut
, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022
Pg. 150-154

Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
Jan/Feb 2022
Pg. 53

Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
Jan/Feb 2022
Pg. 55

Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 57

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377

Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416

Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021
Pg. 422-426

Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2021
Pg. 431-439

Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
Jul/Aug 2021
Pg. 323

Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 325

Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
Jul/Aug 2021
Pg. 328

Calculations
Stockton Shelly J
May/Jun 2021
Pg. 230-231

Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 234

Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui Ada
, Yin Jian, Liu Wei, Zheng Kai
May/Jun 2021
Pg. 246-257

Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 43

Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 44

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 47

Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S
, Schober Joseph M, McPherson Timothy
Jan/Feb 2021
Pg. 48-51

Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 315

Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
Jul/Aug 2020
Pg. 316

Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2020
Pg. 317

Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
Jul/Aug 2020
Pg. 320

Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Song Guiyun
, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
Jul/Aug 2020
Pg. 337-345

Dexamethasone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 225

Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 229

Low-dose Naltrexone Therapy for Psoriasis
Weinstock Leonard B
, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2020
Pg. 94-96

Feasibility Study of Asthma Cream
Kuang Andrew
Mar/Apr 2020
Pg. 163-167

Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 57

LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 59

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 490

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 491

Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2019
Pg. 410

Calculations
Stockton Shelly J
May/Jun 2019
Pg. 229

Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 231

Flunisolide Nasal Spray
Allen Loyd V Jr
May/Jun 2019
Pg. 233

Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2019
Pg. 235

Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
Mar/Apr 2019
Pg. 149

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 150

Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 153

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
Jan/Feb 2019
Pg. 14-21

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jan/Feb 2019
Pg. 52

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 53

Hydrocortisone 2 mg/mL in Inorpha Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 495

Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 497

Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George
, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018
Pg. 270-278

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Williams LaVonn
Jul/Aug 2018
Pg. 284-287

Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 317

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jul/Aug 2018
Pg. 319

Spironolactone 5-mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 152

Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet)
Allen Loyd V Jr
Mar/Apr 2018
Pg. 153

Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 51

Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Jan/Feb 2018
Pg. 54

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 55

Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 58

Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi
, Laracy Melissa, Savji Taslim, Bogner Robin H
Jan/Feb 2018
Pg. 66-75

Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George
, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018
Pg. 76-85

Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George
, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Jan/Feb 2018
Pg. 86-94

Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Nov/Dec 2017
Pg. 494

Tolmetin 400-mg Capsules
Allen Loyd V Jr
Nov/Dec 2017
Pg. 497

Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
Jul/Aug 2017
Pg. 312

Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 319

Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 321

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Graves Richard
, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Jul/Aug 2017
Pg. 334-338

Meloxicam 1% Topical Gel
Allen Loyd V Jr
May/Jun 2017
Pg. 235

Azathioprine 10-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2017
Pg. 146

Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 62

Naproxen 5% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 410

Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José
, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
Jul/Aug 2016
Pg. 333-337

Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 2016
Pg. 228

Indomethacin Gel
Allen Loyd V Jr
May/Jun 2016
Pg. 230

Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
May/Jun 2016
Pg. 232

Blue Goo Anti-Itch Gel
Allen Loyd V Jr
Mar/Apr 2016
Pg. 144

Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
Mar/Apr 2016
Pg. 146

Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
Jan/Feb 2016
Pg. 6-10

Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
Jan/Feb 2016
Pg. 51

Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
Nov/Dec 2015
Pg. 508

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2015
Pg. 405

Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg
Allen Loyd V
Jul/Aug 2015
Pg. 333

Stability of Prednisone in Oral Mix Suspending Vehicle
Friciu Mihaela
, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
Jul/Aug 2015
Pg. 337-339

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 243

Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia
, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
May/Jun 2015
Pg. 261-267

Azathioprine 50-mg Capsules
Allen Loyd V Jr
Jan/Feb 2015
Pg. 61

Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
Jan/Feb 2015
Pg. 66

Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions
Amin Alexandre
, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
Jan/Feb 2015
Pg. 73-77

Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill
, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014
Pg. 370-377

Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 411

Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Robert Marie-Claude
, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2014
Pg. 418-426

Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe
, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Sep/Oct 2014
Pg. 427-431

Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Reisacher William
, Rudner Shara, Kotik Viktoriya
Jul/Aug 2014
Pg. 287-290

Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
Jul/Aug 2014
Pg. 327

Denileukin Diftitox 150-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 328

Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita, Addo Richard T
Jul/Aug 2014
Pg. 348-350

Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 501

Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Allen Loyd V Jr
Nov/Dec 2013
Pg. 504

Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
Sep/Oct 2013
Pg. 380-383

Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 419

Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 421

Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 422

Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 234

Prednisone 10-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 236

Adrenal Fatigue
Allen Loyd V Jr
Jan/Feb 2013
Pg. 39-44

Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 67

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
Nov/Dec 2012
Pg. 462-469

Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 502

Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
Sep/Oct 2012
Pg. 386-393

Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Zur Eyal
Jul/Aug 2012
Pg. 288-293

Betamethasone 0.6-mg/5-mL Syrup
Allen Loyd V Jr
Jul/Aug 2012
Pg. 332

Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 334

Ketorolac Tromethamine 15-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 337

Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A
, Allen Loyd V Jr
May/Jun 2012
Pg. 210-218

Famotidine 10-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 242

Naloxone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 244

Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 246

Ranitidine 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 247

Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste
Dudley Richard
, McDowell Brean, Mahl Carissa, Sarkar Arindam Basu
May/Jun 2012
Pg. 258-261

Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 163

Oral Mucositis: Etiology and Clinical and Pharmaceutical Management
Zur Eyal
Jan/Feb 2012
Pg. 22-33

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Oxandrolone 2-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2011
Pg. 505

Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2011
Pg. 506

Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags
Kaiser Jeanette
, Kramer Irene
Nov/Dec 2011
Pg. 515-520

Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 424

Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 336

Hydrocortisone 100-mg/60-mL Retention Enema
Allen Loyd V Jr
Jul/Aug 2011
Pg. 338

Magnesium Sulfate Paste
Allen Loyd V Jr
Jul/Aug 2011
Pg. 339

Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
Jul/Aug 2011
Pg. 302-307

Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 340

Oxandrolone 1-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 341

Treatment Options for Psoriasis
Williams LaVonn A
, Humphreys Erica
May/Jun 2011
Pg. 204-213

Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 243

Ibuprofen 5% Topical Cream
Allen Loyd V Jr
May/Jun 2011
Pg. 244

Triamcinolone 0.1% Lotion
Allen Loyd V Jr
May/Jun 2011
Pg. 249

Current Concepts in the Treatment of Recurrent Aphthous Ulcers
Bramwell Bethany L
, Williams LaVonn A
Jan/Feb 2011
Pg. 13-18

Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2011
Pg. 64

Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
Jan/Feb 2011
Pg. 65

Ibuprofen 5% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 66

Methotrexate 30-mg/g Topical Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 68

Piroxicam 1% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 69

Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form
Gupta Vishnu D
, Gupta Vikas S
Jan/Feb 2011
Pg. 78-80

Capsaicin 0.05% Clear Medication Stick
Allen Loyd V Jr
Nov/Dec 2010
Pg. 517

Ketoprofen 2% Oral Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 521

Bromhexine Hydrochloride 0.8-mg/mL Syrup
Allen Loyd V Jr
Nov/Dec 2010
Pg. 516

Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 520

Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
Sep/Oct 2010
Pg. 420

Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Santoveña A
, Llabrés M, Fariña JB
Sep/Oct 2010
Pg. 430-435

Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
Sep/Oct 2010
Pg. 427

Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2010
Pg. 336

Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
McElhiney Linda F
Mar/Apr 2010
Pg. 112-115

Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
Mar/Apr 2010
Pg. 151

Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
Jan/Feb 2010
Pg. 68

Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2010
Pg. 74

A Review of Stomatitis and Treatment in Cats
Ray Jody D
, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
Sep/Oct 2009
Pg. 372-381

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

An Abridged History of Aspirin
Vance Dwight A
Sep/Oct 2009
Pg. 404-409

Dexamethasone and Furosemide Injection
Allen Loyd V Jr
Jul/Aug 2009
Pg. 335

Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 157

Nicotine Rectal Enema
Allen Loyd V Jr
Mar/Apr 2009
Pg. 158

Diphenhydramine Hydrochloride 25-mg Gelatin Troches
Allen Loyd V Jr
Jan/Feb 2009
Pg. 69

Excipient Choices for Special Populations
Nagel-Edwards Karen M
, Ko James Y
Sep/Oct 2008
Pg. 426-430

Flurandrenolide Topical Film
Allen Loyd V Jr
Sep/Oct 2008
Pg. 451

Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
Nov/Dec 2008
Pg. 482-487

Zirconium Oxide Lotion
Allen Loyd V Jr
Jul/Aug 2008
Pg. 364

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008
Pg. 295-304

Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization
Westrick Salisa C
, Felkey Bill G
Jul/Aug 2008
Pg. 334-337

Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 360

Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 361

Cyclosporine Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 64

Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 65

Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 66

Flosulide 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 69

Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 71

Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 72

Betamethasone Valerate 0.1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2007
Pg. 419

Diclofenac Sodium 75-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2007
Pg. 421

Hydrocortisone 0.5% Ethanolic Gel
Allen Loyd V Jr
Sep/Oct 2007
Pg. 423

Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form
Gupta Vishnu D
Jul/Aug 2007
Pg. 347-348

Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Gupta Vishnu D
May/Jun 2007
Pg. 259-261

Aspirin 80-mg/5-mL Oral Liquid, Anhydrous
Allen Loyd V Jr
Mar/Apr 2007
Pg. 154

Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vail Jane
Mar/Apr 2007
Pg. 132-135

Triprolidine Hydrochloride 0.25-mg/mL Syrup
Allen Loyd V Jr
Mar/Apr 2007
Pg. 163

Dexamethasone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 72

Prednisone 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 77

Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 78

Cyclophosphamide 2-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 454

Indomethacin 2-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 458

Terbutaline Sulfate 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 460

In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Bigeleisen Paul E
Sep/Oct 2006
Pg. 392-395

Dapsone 2-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 300

Probiotic Therapy, Part 2: Clinical Perspectives
Vail Jane
May/Jun 2006
Pg. 195-200

Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration
Trissel Lawrence A
, Xu Quanyun A, Zhang Yanping
May/Jun 2006
Pg. 234-236

Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together
Gupta Vishnu D
May/Jun 2006
Pg. 237-239

Mycophenolate Mofetil 50-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2006
Pg. 141

Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vail Jane
Mar/Apr 2006
Pg. 107-111

Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
Jan/Feb 2006
Pg. 14-18

View Sample
Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 64

Dexamethasone Oral Powder 10-mg Units, Veterinary
Allen Loyd V Jr
May/Jun 2005
Pg. 226

Return to Top